ByteBrief
We're a portrait publication through and through. Turn your phone back and your briefing picks up right where you left it.
(We tried widescreen once. It wasn't us.)
Telum Therapeutics closed an eighteen million euro series a financing round to advance its drug development pipeline. The biotechnology company will use these funds for research and operational expansion within the healthcare sector.
Tap to vote and see what everyone thinks.
Summary by ByteBrief